Navigation Links
2010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced
Date:11/18/2010

ATLANTA, Nov. 18, 2010 /PRNewswire/ -- UCB, Inc., a global leader in the research and development of medications to treat immunology disorders, today announced the winners of its 2010 UCB Rheumatoid Arthritis Family Scholarship Program for outstanding individuals affected by this condition. UCB is awarding 31 scholarships worth up to $10,000 to help deserving students seek personal growth through higher education.

The scholarship winners include rheumatoid arthritis (RA) patients, as well as family members and caregivers. They were selected not only for their academic ambitions but also for their demonstrated determination to live beyond the boundaries of RA, as shown in their applications and essays.

"This year's scholarship winners are bringing to life UCB's vision of helping people with chronic diseases live better, more productive lives," said David Robinson, vice president and general manager of UCB's Immunology Business Unit. "We work hard to develop patient programs that assist patients live beyond the boundaries of their chronic illnesses."

For five years, UCB has awarded more than 400 scholarships -- totaling more than $3 million -- to individuals living with Crohn's disease, rheumatoid arthritis and epilepsy, as well as their caregivers and family members.

31 Winners, 31 Unique StoriesThe winners of the 2010 UCB Rheumatoid Arthritis Family Scholarship Program have all overcome significant challenges and achieved impressive accomplishments in ways as individual as they are. Among them are:

  • Ashley Atkinson, an animal lover and avid skier, who has competed in the Junior Olympics and has been selected for the U.S. Navy's Marine Mammal internship program
  • Jennifer Horonjeff, a passionate dancer and certified Pilates instructor dedicated to helping others understand the role of exercise in maintaining health and strength
  • John Livingstone, an outdoors and athletics enthusiast who founded his high school's outdoors club, and is an active swimmer, mountain biker, rock climber, runner and surfer
  • Lawrence "Rick" Phillips, a motivated father and husband pursuing a doctorate degree in education to help contribute to the educational setting of online classrooms

  • The full list of the winners is as follows:Jennifer AscolAshley AtkinsonRebecca BernsteinKeara BradyAndrew BrunsCheryl CrowJohn Davis IIIHannah DukeColby EisenbachSamantha FloresLaura FotiHunter GibbonsCarol GilsonAllison GrossMonique HanafinJennifer HoronjeffTiffany JohnsonKara LindquistJohn LivingstonePage MendenhallKatherine MurphyElise NiedermeierNicholas OldbergRhea OrionLawrence PhillipsEmily SmithDiana SpiegelbergChris SwansonHeather TodakDeOnna WhitfieldJennifer ZaikeUsing Facebook to Inspire and InformUCB is harnessing the power of social media to spread the scholarship winners' inspiring examples and messages by launching a Facebook page for the 2010 UCB Rheumatoid Arthritis Family Scholarship Program.

    The scholarship Facebook page will provide a space for current and previous scholarship winners to share their victories while living with a chronic disease. It also will feature a captioned photo album of the 2010 winners; videos of 2010 scholarship winners; updates from current and previous scholarship winners; and links to press releases and media coverage.

    In addition, the scholarship page will keep Facebook users up-to-date on the application process for the 2011 awards.

    2011 Scholarship Application Now AvailableThe 2011 UCB Rheumatoid Arthritis Family Scholarship Program is now open for applications. The downloadable application and more information about the program can be found at www.ReachBeyondRA.com as well as on Facebook.

    UCB offers support to people living with chronic diseases, along with their families and friends, through a broad range of programs that foster independence and empowerment.  The UCB Family Scholarship Program™ is just one such program; for information on others, visit www.UCB-usa.com/patients.

    About Rheumatoid ArthritisRheumatoid arthritis (RA) affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.For Further Information:Bert Kelly, Communications and Public Relations Manager, UCBT: 770.970.8491, Bert.Kelly@ucb.comAbout UCBUCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 000 people in about 40 countries, the company generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

    For further information on UCB products, please visit www.UCB.com.

    Forward-looking statementsThis press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.


    '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
    2. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
    3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
    4. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
    5. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
    6. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
    7. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
    8. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
    9. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
    10. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
    11. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
    (Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
    (Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
    Breaking Medicine Technology:
    (Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
    (Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
    (Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
    (Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
    (Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
    Breaking Medicine News(10 mins):